Oncology or orphan drug share in approved new active substances 2015-2021

Published by
Matej Mikulic,
Sep 7, 2023
This statistic depicts the percentage of orphan and oncology drugs released in Canada and select other developed countries that were new active substances (NAS) from 2015 to 2021. According to the data, in 2021, 42 percent of approved new active substances received an orphan drug designation.

Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2021

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

August 2023

Region

Worldwide

Survey time period

2015 to 2021

Supplementary notes

Includes drugs launched in: Canada, Belgium, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, the United Kingdom, and the United States.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Orphan drugs "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Orphan drugs

Rare diseases

4

Market overview

5

Companies

4

Products

6

Research and development

6

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Orphan drugsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsDiseases
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu